CoChat

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.

Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine

Open access
Nakanishi, Mahito, Otsu, Makoto · 2012 · Current Gene Therapy

Abstract

Gene delivery/expression vectors have been used as fundamental technologies in gene therapy since the 1980s. These technologies are also being applied in regenerative medicine as tools to reprogram cell genomes to a pluripotent state and to other cell lineages. Rapid progress in these new research areas and expectations for their translation into clinical applications have facilitated the development of more sophisticated gene delivery/expression technologies. Since its isolation in 1953 in Japan, Sendai virus (SeV) has been widely used as a research tool in cell biology and in industry, but the application of SeV as a recombinant viral vector has been investigated only recently. Recombinant SeV vectors have various unique characteristics, such as low pathogenicity, powerful capacity for gene expression and a wide host range. In addition, the cytoplasmic gene expression mediated by this vector is advantageous for applications, in that chromosomal integration of exogenous genes can be undesirable. In this review, we introduce a brief historical background on the development of recombinant SeV vectors and describe their current applications in gene therapy. We also describe the application of SeV vectors in advanced nuclear reprogramming and introduce a defective and persistent SeV vector (SeVdp) optimized for such reprogramming.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/156652312802762518

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. (1) Characteristics of Sendai virus. (a) Schematic structure of Sendai virus. Reprinted with the permission of Nikkei Science, Inc. (b) Cross-section view of Sendai virus examined with transmission electron microscopy (courtesy of Dr. Takao Senda, Fujita Health University School of Medicine). (c) Purified Sendai virus in a centrifuge tube. Sendai virus was propagated in 500 fertilized chicken eggs and was purified extensively by sucrose step centrifugation. The large off-white pellet contains about 500 mg of purified Sendai virus as protein.
Fig. (1) Characteristics of Sendai virus. (a) Schematic structure of Sendai virus. Reprinted with the permission of Nikkei Science, Inc. (b) Cross-section view of Sendai virus examined with transmission electron microscopy (courtesy of Dr. Takao Senda, Fujita Health University School of Medicine). (c) Purified Sendai virus in a centrifuge tube. Sendai virus was propagated in 500 fertilized chicken eggs and was purified extensively by sucrose step centrifugation. The large off-white pellet contains about 500 mg of purified Sendai virus as protein.CC BY · PubMed Central
Fig. (2) Genome structure of the Sendai virus. Transcription of capped mRNAs starts from the transcription initiation signal with RNA-dependent RNA polymerase (L protein). Transcription ends at the transcription termination signal, followed by a poly-A signal.
Fig. (2) Genome structure of the Sendai virus. Transcription of capped mRNAs starts from the transcription initiation signal with RNA-dependent RNA polymerase (L protein). Transcription ends at the transcription termination signal, followed by a poly-A signal.CC BY · PubMed Central
Fig. (3) Compatibility of two independent SeVdp vectors in a single cell. (Top) Structure of SeV vectors. cDNA sequences encoding for enhanced green fluorescent protein (EGFP) cDNA and Kusabira orange (KO) were installed on a single SeV vector SeVdp(KO/EGFP) (a) or on two SeV vectors SeVdp(KO) and SeVdp(EGFP) separately (b). (Middle) Fluorescence images of cells expressing KO and EGFP from these SeV vectors. Fluorescence microscopy images of KO and of EGFP were obtained separately with specific filter sets and merged after being converted to an artificial color output (green for EGFP and red for KO). Cells carry a single SeV vector SeVdp(KO/EGFP) (c) or mixture of two SeV vectors SeVdp(KO) and SeVdp(EGFP) (d). (Bottom) Expression levels of KO and EGFP were analyzed quantitatively using flow cytometry. The ratio of the signal intensities of EGFP and KO in each cell is shown as a histogram. Cells carry a single SeV vector SeVdp(KO/EGFP) (e) or mixture of two SeV vectors SeVdp(KO) and SeVdp(EGFP) (f). Reprinted from reference 26 with permission.
Fig. (3) Compatibility of two independent SeVdp vectors in a single cell. (Top) Structure of SeV vectors. cDNA sequences encoding for enhanced green fluorescent protein (EGFP) cDNA and Kusabira orange (KO) were installed on a single SeV vector SeVdp(KO/EGFP) (a) or on two SeV vectors SeVdp(KO) and SeVdp(EGFP) separately (b). (Middle) Fluorescence images of cells expressing KO and EGFP from these SeV vectors. Fluorescence microscopy images of KO and of EGFP were obtained separately with specific filter sets and merged after being converted to an artificial color output (green for EGFP and red for KO). Cells carry a single SeV vector SeVdp(KO/EGFP) (c) or mixture of two SeV vectors SeVdp(KO) and SeVdp(EGFP) (d). (Bottom) Expression levels of KO and EGFP were analyzed quantitatively using flow cytometry. The ratio of the signal intensities of EGFP and KO in each cell is shown as a histogram. Cells carry a single SeV vector SeVdp(KO/EGFP) (e) or mixture of two SeV vectors SeVdp(KO) and SeVdp(EGFP) (f). Reprinted from reference 26 with permission.CC BY · PubMed Central
Fig. (4) Genome structure of defective and persistent Sendai virus (SeVdp) vector. SeVdp has mutations in the L and P genes, which are responsible for low cytotoxicity and for defective induction of IFNβ. The M, F and HN genes are deleted and replaced with genes of interest (A–D). SeVdp-iPS was installed with Oct4, Sox2, Klf4 and c-Myc cDNAs on a single vector.
Fig. (4) Genome structure of defective and persistent Sendai virus (SeVdp) vector. SeVdp has mutations in the L and P genes, which are responsible for low cytotoxicity and for defective induction of IFNβ. The M, F and HN genes are deleted and replaced with genes of interest (A–D). SeVdp-iPS was installed with Oct4, Sox2, Klf4 and c-Myc cDNAs on a single vector.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Research works printed but not linked: 1

  1. [11]Lamb RA Kolakofsky D Paramyxoviridae: The Viruses and Their Replication Fundamental Virology Fourth Edition 2001 689 724

Cited by

See all 149

Metadata

Authors
Nakanishi, M., & Otsu, M.
Affiliations
  • National Institute of Advanced Industrial Science and Technology (JP)
  • Institute of Medical Science, The University of Tokyo (JP)
Corresponding author
Nakanishi, Mahito
Venue
Current Gene Therapy
Published
2012-09-01
Volume
12
Issue
5
Pages
410-416
ISSN
1566-5232 (ISSN-L)
OpenAlex
W2008332694
Cited by
147
References
70
Citations by year
2026: 6 · 2025: 11 · 2024: 19 · 2023: 7 · 2022: 12 · 2021: 11 · 2020: 13 · 2019: 14 · 2018: 15 · 2017: 13 · 2016: 6 · 2015: 8 · 2014: 6 · 2013: 6
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Current Gene Therapy (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institute of Biomedical Innovation
  • Japan Society for the Promotion of Science (24659489)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
Sendai virus, recombinant viral vectors, gene therapy, regenerative medicine, nuclear reprogramming, pluripotency, gene delivery
MeSH terms
Animals, Genetic Vectors, Humans, Genetic Therapy, Gene Expression, Gene Transfer Techniques, Sendai virus, Regenerative Medicine, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine. https://app.cochat.ai/papers/10.2174/156652312802762518
The paper
Nakanishi, M., & Otsu, M. (2012). Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine. Current Gene Therapy. https://doi.org/10.2174/156652312802762518

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.